Australia markets open in 8 hours 31 minutes

Armata Pharmaceuticals, Inc. (ARMP)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.7600+0.2292 (+9.06%)
At close: 03:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 99.76M
Enterprise value 206.61M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.06
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.16

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 378.06%
S&P500 52-week change 322.36%
52-week high 35.2600
52-week low 31.0700
50-day moving average 33.3936
200-day moving average 32.9664

Share statistics

Avg vol (3-month) 315.66k
Avg vol (10-day) 312.81k
Shares outstanding 536.15M
Implied shares outstanding 636.58M
Float 810.72M
% held by insiders 170.35%
% held by institutions 13.63%
Shares short (15 Apr 2024) 49.89k
Short ratio (15 Apr 2024) 40.58
Short % of float (15 Apr 2024) 40.09%
Short % of shares outstanding (15 Apr 2024) 40.03%
Shares short (prior month 15 Mar 2024) 413.32k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 May 2019
Ex-dividend date 4N/A
Last split factor 21:14
Last split date 310 May 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-626.90%

Management effectiveness

Return on assets (ttm)-26.32%
Return on equity (ttm)-3,439.35%

Income statement

Revenue (ttm)4.53M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)45.40%
Gross profit (ttm)N/A
EBITDA -39.92M
Net income avi to common (ttm)-69.05M
Diluted EPS (ttm)-1.9100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.52M
Total cash per share (mrq)0.37
Total debt (mrq)120.37M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.16
Book value per share (mrq)-0.89

Cash flow statement

Operating cash flow (ttm)-47.42M
Levered free cash flow (ttm)-27.75M